Holen Sie sich die Stockscreener-App
29.22
1.22%
-0.36
Handel nachbörslich:
29.22
Schlusskurs vom Vortag:
$29.58
Offen:
$29.6
24-Stunden-Volumen:
556.61K
Relative Volume:
1.48
Marktkapitalisierung:
$953.96M
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
-78.97
EPS:
-0.37
Netto-Cashflow:
$274.29M
1W Leistung:
-9.20%
1M Leistung:
-23.99%
6M Leistung:
-10.01%
1J Leistung:
+16.28%
1-Tages-Spanne:
$28.97
$29.78
1-Wochen-Bereich:
$28.97
$32.18
52-Wochen-Spanne:
$25.13
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| COLL | 29.22 | 953.96M | 566.77M | 48.16M | 274.29M | -0.37 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Amalgamated Bank Has $372,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
121,446 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Bought by Empowered Funds LLC - MarketBeat
Victory Capital Management Inc. Has $27.46 Million Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality - Simply Wall St
Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Rubric Capital Management LP Adjusts Stake in Collegium Pharmace - GuruFocus.com
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Stock Price Down 3.67% on No - GuruFocus.com
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Meritage Portfolio Management Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
New York State Teachers Retirement System Lowers Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Principal Financial Group Inc. Has $67.46 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
Collegium appoints new CEO Vikram Karnani By Investing.com - Investing.com Australia
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? - Yahoo Finance
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates - MSN
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings - MSN
Collegium Pharmaceutical: Q3 Earnings Snapshot - The Washington Post
Collegium Pharmaceutical Reports Strong Q3 2024 Results - TipRanks
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Collegium Pharmaceutical Taps Vikram Karnani as CEO - MarketWatch
Collegium Pharmaceutical earnings beat by $0.04, revenue topped estimates - Investing.com UK
Collegium appoints new CEO Vikram Karnani - Investing.com
Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewswire
Collegium Appoints Vikram Karnani as Chief Executive Officer - GlobeNewswire
Collegium Pharma Names Growth Expert Karnani as CEO Amid Record Revenue Success | COLL Stock News - StockTitan
A Preview Of Collegium Pharmaceutical's Earnings - Benzinga
What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings - Yahoo Finance
Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq
Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World
(COLL) Trading Report - Stock Traders Daily
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - Simply Wall St
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewswire
StockNews.com Downgrades Collegium Pharmaceutical (NASDAQ:COLL) to Buy - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
Collegium Pharmaceutical Inc (COLL) Stock Price Down 3.75% on Oc - GuruFocus.com
(COLL) Investment Report - Stock Traders Daily
Inspire Investing LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):